Treatment of locally advanced head and neck cancer: historical and critical review.
about
Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative ReviewCurative and organ-preserving treatment with intra-arterial carboplatin induction followed by surgery and/or radiotherapy for advanced head and neck cancer: single-center five-year resultsChemoradionuclide therapy with 186re-labeled liposomal doxorubicin: toxicity, dosimetry, and therapeutic response.Use of combination proteomic analysis to demonstrate molecular similarity of head and neck squamous cell carcinoma arising from different subsites.Outcomes of laser thermal therapy for recurrent head and neck cancer.Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research SubcommitteeActivation of Akt at T308 and S473 in alcohol, tobacco and HPV-induced HNSCC: is there evidence to support a prognostic or diagnostic role?Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosisAh receptor antagonism inhibits constitutive and cytokine inducible IL6 production in head and neck tumor cell lines.Feasibility and response of concurrent weekly docetaxel with radical radiotherapy in locally advanced head and neck squamous cell carcinoma.Gefitinib, Methotrexate and Methotrexate plus 5-Fluorouracil as palliative treatment in recurrent head and neck squamous cell carcinomaDiagnosis and management of neck metastases from an unknown primaryFeasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.Aspiration in head and neck cancer patients: a single centre experience of clinical profile, bacterial isolates and antibiotic sensitivity pattern.Treatment outcome of cisplatin-based concurrent chemoradiotherapy in the patients with locally advanced nasopharyngeal cancer.Targeting epidermal growth factor receptor in head and neck cancer: lessons learned from cetuximab.Cohort study of oncologic emergencies in patients with head and neck cancer.Quantitative nanostructural and single-molecule force spectroscopy biomolecular analysis of human-saliva-derived exosomes.Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation.PITX1 is a novel predictor of the response to chemotherapy in head and neck squamous cell carcinoma.Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity.Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy.PEGylated liposome-encapsulated rhenium-188 radiopharmaceutical inhibits proliferation and epithelial-mesenchymal transition of human head and neck cancer cells in vivo with repeated therapy
P2860
Q26783599-9B9D3528-9227-4246-92FF-3A595C7FC1D5Q33281828-5D80BA3D-75D6-4633-AE56-2F8B366831B9Q33396676-8280712B-A06B-4164-AA85-EAB64D407CC7Q33484662-4BA346BF-B83E-4F01-A19A-30EFFAEE177EQ33532932-55568574-6CE0-4867-B569-3112AD5E032DQ34160540-93CA8066-1246-471B-8198-29D4CA3124CFQ34410251-F8B69EA0-CDE5-4ABB-8B2C-F0D65455C80CQ34536056-B8B6EDF0-94FB-4607-B911-F83D0A2F7DF2Q34605176-6D04172F-BECE-4FBB-9EF9-14D80761A407Q35548689-0609E07E-A836-4F4D-BEC0-5A660FFA965EQ36214744-987090E7-30AA-4117-87BA-1EEEF83E3C89Q36218426-E8BC974E-CE2B-4BDF-8E5A-F3AD3F0A9851Q36568927-1FC0A9D0-A2E9-4957-92DD-2802DA38D281Q37034144-5CEDDB57-7BBB-4C08-930F-BE9E5E382AD4Q37230165-447C9E5C-BE1F-4E77-8C66-4AB99336E33AQ37766374-92E75F81-51F3-4A26-80E0-722F0EDC7F3EQ38873680-D8E65F4D-D7BB-4786-B72D-FE89E42E068BQ39713553-7214A244-4C7A-4E99-B2D1-B57D2AD36097Q42355178-7B644F3D-0EC7-4FDB-9B52-D6CA80683CE4Q42576798-20970EFC-7CBE-425C-B303-CC03B17E707FQ45647755-A4916511-4EA8-4D6F-AB40-3F480BBD910FQ55514484-DF0752D0-B0A5-4810-AF18-13C10167898EQ58582649-5DE0F5F1-4961-4257-AA4C-72A78C3C64D8
P2860
Treatment of locally advanced head and neck cancer: historical and critical review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Treatment of locally advanced head and neck cancer: historical and critical review.
@ast
Treatment of locally advanced head and neck cancer: historical and critical review.
@en
Treatment of locally advanced head and neck cancer: historical and critical review.
@nl
type
label
Treatment of locally advanced head and neck cancer: historical and critical review.
@ast
Treatment of locally advanced head and neck cancer: historical and critical review.
@en
Treatment of locally advanced head and neck cancer: historical and critical review.
@nl
prefLabel
Treatment of locally advanced head and neck cancer: historical and critical review.
@ast
Treatment of locally advanced head and neck cancer: historical and critical review.
@en
Treatment of locally advanced head and neck cancer: historical and critical review.
@nl
P2860
P1433
P1476
Treatment of locally advanced head and neck cancer: historical and critical review.
@en
P2093
Muhyi Al-Sarraf
P2860
P304
P356
10.1177/107327480200900504
P577
2002-09-01T00:00:00Z